AIFarm, Ltd.
AIFM · OTC
12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.00 | -40.10 | 470.21 |
| FCF Yield | -95.58% | -118.19% | -0.27% | -0.01% |
| EV / EBITDA | -8.84 | -9.89 | 2,735.65 | -9,902.79 |
| Quality | ||||
| ROIC | 14.35% | 2.42% | 11.85% | 27.35% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 1.08 | 12.73 | -9.70 | 0.97 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | 58.01% | -128.74% | 64.02% | 35.73% |
| Safety | ||||
| Net Debt / EBITDA | 1.47 | 0.88 | -7.15 | -0.29 |
| Interest Coverage | 0.00 | 0.00 | -78.71 | -79.68 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |